Who Abingworth invests alongside: Atlas Venture, EcoR1 Capital, Omega Funds — mapped across 13 portfolio companies in 1 sectors and 7 cities.
Abingworth accounts for 31 tracked companies with verified cap-table data, 31 of which disclose round sizes totalling $7.1B. The median disclosed raise is $120M, and the largest is Vaxcyte at $2.4B, ahead of Tubulis ($575M) and AdvanCell ($440M).
The names that recur most often on these co-invested cap tables are Abingworth (31 companies), Osage University Partners (5 companies), Atlas Venture (5 companies), 4BIO Capital (4 companies), Surveyor Capital (4 companies), Omega Funds (4 companies). By latest disclosed round, the market skews Series A (15), Series B (7), Series C (2), IPO (1).
Companies tracked: 31
Disclosed funding total: $7.1B across 31 companies
Median disclosed raise: $120M
Largest raise: Vaxcyte — $2.4B
Stage mix: Series A 15 · Series B 7 · Series C 2 · IPO 1
